In the clinic, olanzapine therapy tends to result in weight gain and
Number of reports, temporal relationship to start of olanzapine therapy, relatively young
Application error: a client-side exception has occurred (see the browser console for more
Background Non-alcoholic fatty liver disease (NAFLD) describes a
Olanzapine (Zyprexa) can also be used to treat depression, in combination with fluoxetine (Prozac), when other treatments haven't worked well
His hemoglobin A 1c (HbA 1c) level rose from a baseline of 5
itching of the vagina or genital area
population, or 34
Olanzapine (Zyprexa) is a second-generation antipsychotic (SGA) FDA-approved for schizophrenia and bipolar 1 disorder as monotherapy or in combination with lithium or valproate
2% of patients on a typical phenothiazine developed evidence of new onset diabetes compared with 8
In the study cited in the Nielsen J, Gerhard T, Carbon M, et al
As stated previously, if damage is extensive there is no cure for The ZYPREXA 2
Olanzapine is also approved for use with fluoxetine, a selective serotonin reuptake inhibitor (SSRI), in patients with GDM is an independent risk factor for developing type 2 diabetes mellitus later in life and is a common complication affecting approximately 15% of pregnancies worldwide
Effective dosage in clinical studies generally ranged from 2
To evaluate risk of new-onset type 2 diabetes associated with use of selected antipsychotic agents, the authors conducted a new-user cohort study in a national sample of US Veterans Health Administration patients with schizophrenia (and no preexisting diabetes)
This risk increased with longer-term use of antidepressants and higher dosages
Increasing antipsychotic use among children and youth 1-4 raises the concern that this practice increases the risk of type 2 diabetes mellitus in this vulnerable population
1)